Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014)

Background and purpose In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Strahlentherapie und Onkologie Ročník 195; číslo 1; s. 43 - 51
Hlavní autoři: Francolini, Giulio, Desideri, Isacco, Meattini, Icro, Becherini, Carlotta, Terziani, Francesca, Olmetto, Emanuela, Delli Paoli, Camilla, Pezzulla, Donato, Loi, Mauro, Bonomo, Pierluigi, Greto, Daniela, Calusi, Silvia, Casati, Marta, Pallotta, Stefania, Livi, Lorenzo
Médium: Journal Article
Jazyk:angličtina
Vydáno: Berlin/Heidelberg Springer Berlin Heidelberg 01.01.2019
Témata:
ISSN:0179-7158, 1439-099X, 1439-099X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background and purpose In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made. Patients and methods Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD. Results Mean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97. Conclusion Results showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.
AbstractList In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made.BACKGROUND AND PURPOSEIn our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made.Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD.PATIENTS AND METHODSHeart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD.Mean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97.RESULTSMean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97.Results showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.CONCLUSIONResults showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.
Background and purpose In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made. Patients and methods Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD. Results Mean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97. Conclusion Results showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.
In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made. Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD. Mean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97. Results showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.
Author Calusi, Silvia
Becherini, Carlotta
Livi, Lorenzo
Loi, Mauro
Terziani, Francesca
Olmetto, Emanuela
Delli Paoli, Camilla
Bonomo, Pierluigi
Casati, Marta
Desideri, Isacco
Greto, Daniela
Pallotta, Stefania
Francolini, Giulio
Meattini, Icro
Pezzulla, Donato
Author_xml – sequence: 1
  givenname: Giulio
  surname: Francolini
  fullname: Francolini, Giulio
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 2
  givenname: Isacco
  surname: Desideri
  fullname: Desideri, Isacco
  email: isacco.desideri@unifi.it
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 3
  givenname: Icro
  surname: Meattini
  fullname: Meattini, Icro
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 4
  givenname: Carlotta
  surname: Becherini
  fullname: Becherini, Carlotta
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 5
  givenname: Francesca
  surname: Terziani
  fullname: Terziani, Francesca
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 6
  givenname: Emanuela
  surname: Olmetto
  fullname: Olmetto, Emanuela
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 7
  givenname: Camilla
  surname: Delli Paoli
  fullname: Delli Paoli, Camilla
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 8
  givenname: Donato
  surname: Pezzulla
  fullname: Pezzulla, Donato
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 9
  givenname: Mauro
  surname: Loi
  fullname: Loi, Mauro
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 10
  givenname: Pierluigi
  surname: Bonomo
  fullname: Bonomo, Pierluigi
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 11
  givenname: Daniela
  surname: Greto
  fullname: Greto, Daniela
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
– sequence: 12
  givenname: Silvia
  surname: Calusi
  fullname: Calusi, Silvia
  organization: Department of Clinical and Experimental Biomedical Sciences “Mario Serio”, University of Florence
– sequence: 13
  givenname: Marta
  surname: Casati
  fullname: Casati, Marta
  organization: Medical Physics Unit-AOU Careggi
– sequence: 14
  givenname: Stefania
  surname: Pallotta
  fullname: Pallotta, Stefania
  organization: Medical Physics Unit-AOU Careggi
– sequence: 15
  givenname: Lorenzo
  surname: Livi
  fullname: Livi, Lorenzo
  organization: Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30406290$$D View this record in MEDLINE/PubMed
BookMark eNp9kbFuFDEURS2UiGwCH0CDXNIY7PGMZ1xGEQGkSDRESmd57Dcbr2Y9i5-NNh_Af-NkAgVFqtecc5907zk5iUsEQt4J_lFw3n9CzrlSjIuBCTkM7PiKbEQrNeNa352QDRe9Zr3ohjNyjrjjXKhWt6_JmeQtV43mG_L7EhEQ9xAzXSZq6bYED3OIwEaL4Ok92JQplhFzKi6XBEhXwOawRBoinWHKDKvm6ZjAYqbORgeJHipSg5GW6CFtlxC31Ppd-WXrt2R9WPI9JHt4eENOJzsjvH2-F-T2-vOPq6_s5vuXb1eXN8w1nT4yYRVvQVno9TQo3w5eDrKbXNdM06id7rrWdo1sfCOkcz103vnRgxzGXgk5jfKCfFhzD2n5WQCz2Qd0MM82wlLQVE80Ugo1VPT9M1rGPXhzSGFv04P5W10FxAq4tCAmmP4hgpvHecw6j6nzmMd5zLE6_X-OC_mpx5xsmF80m9XE-iVuIZndUlKsZb0g_QHU_qhb
CitedBy_id crossref_primary_10_3389_fcvm_2020_00016
crossref_primary_10_3389_fonc_2020_01708
crossref_primary_10_1016_j_ijrobp_2022_11_021
crossref_primary_10_1007_s00432_021_03875_1
crossref_primary_10_2478_raon_2020_0050
Cites_doi 10.1016/j.ijrobp.2009.04.093
10.1016/j.radonc.2017.01.008
10.1016/j.ijrobp.2017.05.030
10.1016/j.clon.2010.05.006
10.1186/s13014-016-0627-5
10.1007/s12032-017-0938-x
10.1016/j.radonc.2016.04.041
10.1016/j.ijrobp.2008.10.034
10.1016/j.radonc.2013.06.025
10.1056/NEJMoa1209825
10.1016/j.ijrobp.2009.10.058
10.1016/j.jacc.2010.11.063
10.1109/42.363096
10.1007/s11548-015-1266-2
10.3109/0284186X.2013.813069
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2018
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s00066-018-1388-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Bewertung einer leitlinienbasierten Konturierung von Herzunterstrukturen bei linksseitigen Brustkrebspatientinnen im Rahmen einer adjuvanten Strahlentherapie : Qualitätsbeurteilung innerhalb einer Phase-III-Studie zum Test einer kardioprotektiven Behandlungsstrategie (SAFE-2014)
DocumentTitle_FL Bewertung einer leitlinienbasierten Konturierung von Herzunterstrukturen bei linksseitigen Brustkrebspatientinnen im Rahmen einer adjuvanten Strahlentherapie
EISSN 1439-099X
EndPage 51
ExternalDocumentID 30406290
10_1007_s00066_018_1388_x
Genre Clinical Trial, Phase III
Comparative Study
Randomized Controlled Trial
Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-~C
.86
.VR
04C
06C
06D
0R~
0VY
123
1N0
203
29Q
29~
2J2
2JN
2JY
2KG
2LR
2~H
30V
4.4
406
408
409
40D
40E
5RE
5VS
67Z
6NX
7RV
7X7
88E
8AO
8C1
8FE
8FG
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGLVJ
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CCPQU
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIHBH
EIOEI
EJD
EMB
EMOBN
ESBYG
EX3
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N9A
NAPCQ
NB0
NPVJJ
NQJWS
NU0
O93
O9I
O9J
OAM
P62
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
ROL
RPX
RRX
RSV
S16
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z87
ZMTXR
ZOVNA
-Y2
1SB
2P1
2VQ
3O-
53G
AANXM
AAPKM
AARHV
AAYXX
ABBRH
ABDBE
ABFSG
ABQSL
ABRTQ
ABULA
ACBXY
ACSTC
ADHKG
AEBTG
AEKMD
AEZWR
AFDZB
AFFHD
AFHIU
AFOHR
AGQPQ
AHPBZ
AHSBF
AHWEU
AIXLP
AJBLW
ATHPR
AYFIA
CAG
CITATION
COF
DARCH
EN4
H13
IHE
N2Q
O9-
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
S1Z
UDS
X7J
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
RIG
7X8
PUEGO
ID FETCH-LOGICAL-c259x-1a604e6ae79f86d48d3835fc52ffb9c9554a5232d213cc7e5dcdbde38b7613fb3
IEDL.DBID RSV
ISSN 0179-7158
1439-099X
IngestDate Fri Sep 05 09:24:25 EDT 2025
Mon Jul 21 05:35:58 EDT 2025
Sat Nov 29 02:35:49 EST 2025
Tue Nov 18 21:04:22 EST 2025
Fri Feb 21 02:33:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Anthracyclines
Anthrazykline
Ramipril
Kardiovaskuläre Erkrankungen
Bisoprolol
Cardiovascular diseases
Trastuzumab
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c259x-1a604e6ae79f86d48d3835fc52ffb9c9554a5232d213cc7e5dcdbde38b7613fb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 30406290
PQID 2131233168
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2131233168
pubmed_primary_30406290
crossref_primary_10_1007_s00066_018_1388_x
crossref_citationtrail_10_1007_s00066_018_1388_x
springer_journals_10_1007_s00066_018_1388_x
PublicationCentury 2000
PublicationDate 2019-Jan
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-Jan
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
PublicationSubtitle Journal of Radiation Oncology, Biology, Physics
PublicationTitle Strahlentherapie und Onkologie
PublicationTitleAbbrev Strahlenther Onkol
PublicationTitleAlternate Strahlenther Onkol
PublicationYear 2019
Publisher Springer Berlin Heidelberg
Publisher_xml – name: Springer Berlin Heidelberg
References Lo, Hee, Batumalai (CR11) 2017; 99
Lorenzen, Taylor, Maraldo (CR13) 2013; 108
Jacob, Pathak, Franck (CR12) 2016; 11
Duane, Aznar, Bartlett (CR2) 2017; 122
Hanna, Hounsell, O’Sullivan (CR5) 2010; 22
Feng, Moran, Koelling (CR8) 2011; 79
Fallah-Rad, Walker, Wassef (CR15) 2011; 57
Mattiucci, Boldrini, Chiloiro (CR7) 2013; 52
Dolz, Laprie, Ken (CR4) 2016; 11
Zijdenbos, Dawant, Margolin (CR6) 1994; 13
Gagliardi, Constine, Moiseenko (CR14) 2010; 76
Dipasquale, Wang, Chatelain-Fontanella (CR10) 2016; 120
Meattini, Curigliano, Terziani (CR3) 2017; 34
Li, Tai, Arthur (CR9) 2009; 73
Darby, Ewertz, McGale (CR1) 2013; 368
J Dolz (1388_CR4) 2016; 11
AP Zijdenbos (1388_CR6) 1994; 13
GG Hanna (1388_CR5) 2010; 22
S Jacob (1388_CR12) 2016; 11
M Feng (1388_CR8) 2011; 79
EL Lorenzen (1388_CR13) 2013; 108
GC Mattiucci (1388_CR7) 2013; 52
Q Lo (1388_CR11) 2017; 99
G Dipasquale (1388_CR10) 2016; 120
G Gagliardi (1388_CR14) 2010; 76
I Meattini (1388_CR3) 2017; 34
XA Li (1388_CR9) 2009; 73
SC Darby (1388_CR1) 2013; 368
N Fallah-Rad (1388_CR15) 2011; 57
F Duane (1388_CR2) 2017; 122
References_xml – volume: 76
  start-page: S77
  issue: 3 Suppl
  year: 2010
  end-page: S85
  ident: CR14
  article-title: Radiation dose-volume effects in the heart
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.04.093
– volume: 122
  start-page: 416
  issue: 3
  year: 2017
  end-page: 422
  ident: CR2
  article-title: A cardiac contouring atlas for radiotherapy
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2017.01.008
– volume: 99
  start-page: 182
  issue: 1
  year: 2017
  end-page: 190
  ident: CR11
  article-title: Strain imaging detects dose-dependent segmental cardiac dysfunction in the acute phase after breast irradiation
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.05.030
– volume: 22
  start-page: 515
  year: 2010
  end-page: 525
  ident: CR5
  article-title: Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods
  publication-title: Clin Oncol (R Coll Radiol)
  doi: 10.1016/j.clon.2010.05.006
– volume: 11
  start-page: 54
  issue: 1
  year: 2016
  ident: CR12
  article-title: Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: The BACCARAT prospective cohort study
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-016-0627-5
– volume: 34
  start-page: 75
  issue: 5
  year: 2017
  ident: CR3
  article-title: SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
  publication-title: Med Oncol
  doi: 10.1007/s12032-017-0938-x
– volume: 120
  start-page: 124
  issue: 1
  year: 2016
  end-page: 127
  ident: CR10
  article-title: Automatic segmentation of breast in prone position: correlation of similarity indexes and breast pendulousness with dose/volume parameters
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2016.04.041
– volume: 73
  start-page: 944
  year: 2009
  end-page: 951
  ident: CR9
  article-title: Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.10.034
– volume: 108
  start-page: 254
  issue: 2
  year: 2013
  end-page: 258
  ident: CR13
  article-title: Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2013.06.025
– volume: 368
  start-page: 987
  issue: 11
  year: 2013
  end-page: 998
  ident: CR1
  article-title: Risk of ischemic heart disease in women after radiotherapy for breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1209825
– volume: 79
  start-page: 10
  issue: 1
  year: 2011
  end-page: 18
  ident: CR8
  article-title: Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2009.10.058
– volume: 57
  start-page: 2263
  issue: 22
  year: 2011
  end-page: 2270
  ident: CR15
  article-title: The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.11.063
– volume: 13
  start-page: 716
  year: 1994
  end-page: 724
  ident: CR6
  article-title: Morphometric analysis of white matter lesions in MR images: method and validation
  publication-title: IEEE Trans Med Imaging
  doi: 10.1109/42.363096
– volume: 11
  start-page: 43
  issue: 1
  year: 2016
  end-page: 51
  ident: CR4
  article-title: Supervised machine learning-based classification scheme to segment the brainstem on MRI in multicenter brain tumor treatment context
  publication-title: Int J Comput Assist Radiol Surg
  doi: 10.1007/s11548-015-1266-2
– volume: 52
  start-page: 1417
  year: 2013
  end-page: 1422
  ident: CR7
  article-title: Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark?
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2013.813069
– volume: 122
  start-page: 416
  issue: 3
  year: 2017
  ident: 1388_CR2
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2017.01.008
– volume: 108
  start-page: 254
  issue: 2
  year: 2013
  ident: 1388_CR13
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2013.06.025
– volume: 76
  start-page: S77
  issue: 3 Suppl
  year: 2010
  ident: 1388_CR14
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.04.093
– volume: 79
  start-page: 10
  issue: 1
  year: 2011
  ident: 1388_CR8
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2009.10.058
– volume: 22
  start-page: 515
  year: 2010
  ident: 1388_CR5
  publication-title: Clin Oncol (R Coll Radiol)
  doi: 10.1016/j.clon.2010.05.006
– volume: 73
  start-page: 944
  year: 2009
  ident: 1388_CR9
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.10.034
– volume: 120
  start-page: 124
  issue: 1
  year: 2016
  ident: 1388_CR10
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2016.04.041
– volume: 57
  start-page: 2263
  issue: 22
  year: 2011
  ident: 1388_CR15
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.11.063
– volume: 34
  start-page: 75
  issue: 5
  year: 2017
  ident: 1388_CR3
  publication-title: Med Oncol
  doi: 10.1007/s12032-017-0938-x
– volume: 13
  start-page: 716
  year: 1994
  ident: 1388_CR6
  publication-title: IEEE Trans Med Imaging
  doi: 10.1109/42.363096
– volume: 11
  start-page: 43
  issue: 1
  year: 2016
  ident: 1388_CR4
  publication-title: Int J Comput Assist Radiol Surg
  doi: 10.1007/s11548-015-1266-2
– volume: 368
  start-page: 987
  issue: 11
  year: 2013
  ident: 1388_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1209825
– volume: 99
  start-page: 182
  issue: 1
  year: 2017
  ident: 1388_CR11
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2017.05.030
– volume: 11
  start-page: 54
  issue: 1
  year: 2016
  ident: 1388_CR12
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-016-0627-5
– volume: 52
  start-page: 1417
  year: 2013
  ident: 1388_CR7
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2013.813069
SSID ssj0016494
Score 2.2176595
Snippet Background and purpose In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular...
In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014,...
In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014,...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 43
SubjectTerms Algorithms
Bisoprolol - administration & dosage
Cardiotonic Agents - administration & dosage
Chemotherapy, Adjuvant - methods
Combined Modality Therapy - methods
Drug Therapy, Combination
Echocardiography, Doppler - methods
Female
Guideline Adherence
Heart - drug effects
Heart - radiation effects
Humans
Medicine
Medicine & Public Health
Observer Variation
Oncology
Original Article
Quality Assurance, Health Care
Radiation Injuries - diagnostic imaging
Radiation Injuries - prevention & control
Radiometry - methods
Radiotherapy
Radiotherapy, Adjuvant - methods
Ramipril - administration & dosage
Reproducibility of Results
Unilateral Breast Neoplasms - drug therapy
Unilateral Breast Neoplasms - radiotherapy
Subtitle Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014)
Title Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy
URI https://link.springer.com/article/10.1007/s00066-018-1388-x
https://www.ncbi.nlm.nih.gov/pubmed/30406290
https://www.proquest.com/docview/2131233168
Volume 195
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: Springer Journals
  customDbUrl:
  eissn: 1439-099X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016494
  issn: 0179-7158
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB50FfHF-1gvIvikBLZnksdFFB9UxIt9K2kOWZGubLuiP8D_7aQXiAfoW6FpGjKTzDeZzDcAB6zn2zT0LLVB6tNQmIgKI_CJa_QnNDocJTv__Tm7vOSDgbiq87jz5rZ7E5Isd-o22a00j-j6csebxykCxxm0dtzVa7i-uW9DB3EoKkJvJijzIt6EMr_r4rMx-oIwv0RHS6Nzuviv4S7BQo0xSb9SimWYMtkKzF3UUfRVeO-3dJxkZIkkDxNHdoXvqDNqmrgq1wXJcU8p2WUn6JKTqkEpRzLMyJOxBXWlPjVJ3b32giinP2NSE7XmxGWnjR9GOGYi9eMEEXtBxlIP65SvtzW4Oz25PT6jdTkGqtBHeqWejHuhiaVhwvJYozTRu42sinxrU6EEAhOJbq2vfS9QiplIK51qE_CUIWawabAOnWyUmU0gRmjheFGtRHhhjSe9SKPOxJZFyojQdKHXyCVRNVe5K5nxlLQsy-X0Jji9iZve5LULh-0nzxVRx2-N9xthJ7icXIxEZmY0yRMcO9pyV82rCxuVFrTdBbjhxb7odeGoEXlSr_j8539t_an1NswjJBPVIc8OdFDMZhdm1UsxzMd7MM0GfK_U9w_5lfys
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB5ERX3xPtYzgk9KYHs3j4soiusiXvgW0hyyIl3ZdmX9Af5vJ71APEDfCk3TkJlkvslkvgE4iNquSXzHUOMlLvWZDijTDJ9ihf6EQoejYOe_70a9XvzwwK6qPO6svu1ehySLnbpJdivMI7q-seXNiykCxykfDZYlzL--uW9CB6HPSkLviNHICeI6lPldF5-N0ReE-SU6Whid04V_DXcR5iuMSTqlUizBhE6XYeayiqKvwHunoeMkA0MEeRxZsit8R61RU8RWuc5JhntKwS47QpeclA0KOZJ-Sp61yakt9alIYu-150Ra_RmSiqg1IzY7bfg4wDEToZ5GiNhzMhSqX6V8va3C3enJ7fEZrcoxUIk-0pg6Imz7OhQ6YiYOFUoTvdvAyMA1JmGSITAR6Na6ynU8KSMdKKkSpb04iRAzmMRbg8l0kOoNIJopZnlRjUB4YbQjnEChzoQmCqRmvm5Bu5YLlxVXuS2Z8cwbluViejlOL7fTy8ctOGw-eSmJOn5rvF8Lm-NysjESkerBKOM4drTltppXC9ZLLWi683DDC13WbsFRLXJerfjs539t_qn1Hsye3V52efe8d7EFcwjPWHngsw2TKHK9A9PyNe9nw91C6z8A5cP-qA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB5ERXzxPtYzgk9KcHs3j4u6KK6L4IFvIc0hK9KVbVf0B_i_nfQC8QDxrdC0DZlJ5vs6yTcA-1HbNYnvGGq8xKU-0wFlmuFVrJBPKCQchTr_XS_q9-P7e3ZV1TnN6t3udUqyPNNgVZrS_OhZmaPm4FsRKpEGx1ZDL6YIIqd8u4_e0vXruyaNEPqsFPeOGI2cIK7Tmt-94nNg-oI2v2RKiwDUnf931xdgrsKepFM6yyJM6HQJZi6r7PoyvHcamU4yNESQh7EVwcJ71AY7RWz165xkuNYUqrNjpOqkbFDYlwxS8qRNTm0JUEUSu989J9L61YhUAq4ZsafWRg9D7D8R6nGMSD4nI6EG1VGwtxW47Z7eHJ_RqkwDlcidXqkjwravQ6EjZuJQoZWR9QZGBq4xCZMMAYtAuusq1_GkjHSgpEqU9uIkQixhEm8VJtNhqteBaKaY1Us1AmGH0Y5wAoW-FJookJr5ugXt2kZcVhrmtpTGE2_Ul4vh5Ti83A4vf23BQfPIcyng8VvjvdrwHKeZzZ2IVA_HGce-Y4y3Vb5asFZ6RPM6DxfC0GXtFhzW5ufVSpD9_K2NP7XehZmrky7vnfcvNmEWURsr_wNtwSRaXG_DtHzJB9lop5gAH_bSB5s
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+a+guideline-based+heart+substructures+delineation+in+left-sided+breast+cancer+patients+undergoing+adjuvant+radiotherapy+%3A+Quality+assessment+within+a+randomized+phase+III+trial+testing+a+cardioprotective+treatment+strategy+%28SAFE-2014%29&rft.jtitle=Strahlentherapie+und+Onkologie&rft.au=Francolini%2C+Giulio&rft.au=Desideri%2C+Isacco&rft.au=Meattini%2C+Icro&rft.au=Becherini%2C+Carlotta&rft.date=2019-01-01&rft.issn=1439-099X&rft.eissn=1439-099X&rft.volume=195&rft.issue=1&rft.spage=43&rft_id=info:doi/10.1007%2Fs00066-018-1388-x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-7158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-7158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-7158&client=summon